Need help finding what you are looking for?
Contact Us
PUBLISHER: DelveInsight | PRODUCT CODE: 2082719
PUBLISHER: DelveInsight | PRODUCT CODE: 2082719
Diabetic Foot Ulcers (DFUs) - Epidemiology Forecast - 2036
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Diabetic Foot Ulcer (DFU) Epidemiology Insights and Trends
- DFU is a chronic, non-healing wound that commonly occurs on the feet of patients with diabetes due to peripheral neuropathy, poor blood circulation, and impaired wound healing. DFUs are associated with a high risk of infection, hospitalization, and lower-limb amputation.
- The major types of DFU include neuropathic ulcers, caused primarily by nerve damage and loss of protective sensation; ischemic ulcers, resulting from inadequate blood supply due to peripheral arterial disease; and neuroischemic ulcers, which involve both neuropathy and ischemia and are often more difficult to heal.
- DFU is more prevalent in Asian countries such as Japan due to the rising prevalence of diabetes mellitus, increasing aging population, high burden of peripheral neuropathy and peripheral arterial disease, and delayed wound recognition and treatment, which collectively contribute to higher rates of chronic non-healing ulcers and complications.
- Males face a higher lifetime risk of developing DFU and experience a greater disease burden compared to females. This disparity is largely attributed to higher prevalence of risk factors such as smoking, poorer glycemic control, increased rates of peripheral arterial disease and neuropathy, delayed health-seeking behavior, and lower adherence to preventive foot care practices.
- Increasing global prevalence of diabetes mellitus, population aging, rising obesity rates, sedentary lifestyles, and poor glycemic control are expected to sustain the global DFU burden over the next decade. Strengthening diabetes management programs, improving early identification of high-risk patients through routine foot screening, and expanding access to advanced wound care therapies and multidisciplinary foot care services will remain key determinants of future trends.
Diabetic Foot Ulcer (DFU) Epidemiology Forecast in 7MM
- 2025 Prevalent Cases of DFU: ~ 6,600,000
- DFU Growth Rate (2026-2036): ~10% CAGR
DelveInsight's 'Diabetic Foot Ulcer (DFU) - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the DFU, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Diabetic Foot Ulcer (DFU) Understanding and Diagnosis Algorithm
DFU Overview
DFU is a serious and common complication of diabetes, arising from a combination of peripheral neuropathy, peripheral arterial disease, and impaired wound healing. It occurs when minor trauma or pressure on the foot goes unnoticed due to loss of sensation, leading to skin breakdown and chronic ulcer formation. DFUs can range from superficial wounds to deep ulcers involving muscle and bone, often accompanied by infection in advanced stages. Common symptoms include non-healing wounds, redness, swelling, discharge, and, in severe cases, tissue necrosis. DFU is primarily caused by prolonged hyperglycemia, poor circulation, and repetitive mechanical stress. Diagnosis is based on clinical examination, wound assessment, and vascular evaluation.
DFU Diagnosis
DFU is diagnosed through clinical examination and supportive tests, often detected during routine foot checks in diabetic patients. Physical assessment focuses on ulcer size, depth, infection signs, and evaluation of neuropathy and blood circulation. Blood tests such as glucose levels and HbA1c assess glycemic control, while imaging (X-ray or MRI) may be used to detect deep infection or osteomyelitis. Vascular tests like ankle-brachial index (ABI) help identify poor blood flow, and wound cultures may be performed to guide treatment in infected ulcers.
Diabetic Foot Ulcer (DFU) Epidemiology
Key Findings from DFU Epidemiological Analysis and Forecast
- According to DelveInsight's estimates, the total prevalent cases of DFU in the 7MM were approximately 6,600, 000 in 2025.
- Among the EU4, Italy accounted for the highest number of prevalent cases of DFU, followed by Germany, whereas Spain accounted for the lowest number of cases in 2025.
- The observed male predominance and earlier onset of DFU highlight the importance of early risk stratification, routine foot screening, and targeted preventive care strategies in high-risk populations to reduce complications and improve outcomes.
- The prevalence of DFU was 77% in the US population. Females had a lower prevalence of DFU than males.
Scope of the Report:
- The report covers a segment of an executive summary, a descriptive overview of DFU, explaining its causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Report Insights
Diabetic Foot Ulcer (DFU) Patient Population Forecast
Report Key Strengths
- Epidemiology-based (epi-based) Bottom-up Forecasting
- 11-year Forecast
- Patient Burden Trends (by Geography)
FAQs:
- What are the disease risks, burdens, and unmet needs of DFU? What will be the growth opportunities across the 7MM concerning the patient population with DFU?
- What is the historical and forecasted DFU patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy:
- Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders' perspectives around the diagnostic challenges to overcome barriers in the future.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
Product Code: DIEI0273
Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary of Diabetic Foot Ulcer (DFU)
4. Epidemiology Forecast Methodology of Diabetic Foot Ulcer (DFU)
5. Diabetic Foot Ulcer (DFU) Epidemiology Overview at a Glance
- 5.1. Patient Share (%) Distribution by Country in 2025 in the 7MM
- 5.2. Patient Share (%) Distribution by Country in 2036 in the 7MM
6. Disease Background and Overview of Diabetic Foot Ulcer (DFU)
- 6.1. Introduction
- 6.2. Signs and Symptoms
- 6.3. Causes
- 6.4. Risk Factors Associated With DFU
- 6.5. Pathophysiology
- 6.6. Diagnosis
- 6.6.1. Differential Diagnosis
- 6.6.2. Diagnosis Algorithm
- 6.6.3. Diagnosis Guidelines
7. Epidemiology and Patient Population of Diabetic Foot Ulcer (DFU)
- 7.1. Key Findings
- 7.2. Assumptions and Rationale
- 7.3. Total Prevalent Cases of DFU in the 7MM
- 7.4. The United States
- 7.4.1. Diabetic Foot Ulcer Prevalent Cases in the United States
- 7.4.2. Diabetic Foot Ulcer Diagnosed Prevalent Cases in the United States
- 7.4.3. Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in the United States
- 7.4.4. Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in the United States
- 7.4.5. Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in the United States
- 7.4.6. Diabetic Foot Ulcer Total Treated Cases in the United States
- 7.5. EU4 and the UK
- 7.5.1. Diabetic Foot Ulcer Prevalent Cases in EU4 and the UK
- 7.5.2. Diabetic Foot Ulcer Diagnosed Prevalent Cases in EU4 and the UK
- 7.5.3. Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in EU4 and the UK
- 7.5.4. Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in EU4 and the UK
- 7.5.5. Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in EU4 and the UK
- 7.5.6. Diabetic Foot Ulcer Total Treated Cases in EU4 and the UK
- 7.6. Japan
- 7.6.1. Diabetic Foot Ulcer Prevalent Cases in Japan
- 7.6.2. Diabetic Foot Ulcer Diagnosed Prevalent Cases in Japan
- 7.6.3. Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in Japan
- 7.6.4. Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in Japan
- 7.6.5. Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in Japan
- 7.6.6. Diabetic Foot Ulcer Total Treated Cases in Japan
8. Appendix
- 8.1. Bibliography
- 8.2. Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
Product Code: DIEI0273
List of Tables
- Table 1: Summary of DFU: Market, Epidemiology, and Key Events (2022-2036)
- Table 2: Differential Diagnosis of DFU
- Table 3: The United States
- Table 4: Diabetic Foot Ulcer Prevalent Cases in the United States
- Table 5: Diabetic Foot Ulcer Diagnosed Prevalent Cases in the United States
- Table 6: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in the United States
- Table 7: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in the United States
- Table 8: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in the United States
- Table 9: Diabetic Foot Ulcer Total Treated Cases in the United States
- Table 10: EU4 and the UK
- Table 11: Diabetic Foot Ulcer Prevalent Cases in EU4 and the UK
- Table 12: Diabetic Foot Ulcer Diagnosed Prevalent Cases in EU4 and the UK
- Table 13: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in EU4 and the UK
- Table 14: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in EU4 and the UK
- Table 15: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in EU4 and the UK
- Table 16: Diabetic Foot Ulcer Total Treated Cases in EU4 and the UK
- Table 17: Japan
- Table 18: Diabetic Foot Ulcer Prevalent Cases in Japan
- Table 19: Diabetic Foot Ulcer Diagnosed Prevalent Cases in Japan
- Table 20: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in Japan
- Table 21: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in Japan
- Table 22: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in Japan
- Table 23: Diabetic Foot Ulcer Total Treated Cases in Japan
List of Figures
- Figure 1: Signs and Symptoms of DFU
- Figure 2: Risk Factors of DFU
- Figure 3: Differential Diagnosis of DFU
- Figure 4: Diagnostic Algorithm for DFU
- Figure 5: The United States
- Figure 6: Diabetic Foot Ulcer Prevalent Cases in the United States
- Figure 7: Diabetic Foot Ulcer Diagnosed Prevalent Cases in the United States
- Figure 8: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in the United States
- Figure 9: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in the United States
- Figure 10: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in the United States
- Figure 11: Diabetic Foot Ulcer Total Treated Cases in the United States
- Figure 12: EU4 and the UK
- Figure 13: Diabetic Foot Ulcer Prevalent Cases in EU4 and the UK
- Figure 14: Diabetic Foot Ulcer Diagnosed Prevalent Cases in EU4 and the UK
- Figure 15: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in EU4 and the UK
- Figure 16: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in EU4 and the UK
- Figure 17: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in EU4 and the UK
- Figure 18: Diabetic Foot Ulcer Total Treated Cases in EU4 and the UK
- Figure 19: Japan
- Figure 20: Diabetic Foot Ulcer Prevalent Cases in Japan
- Figure 21: Diabetic Foot Ulcer Diagnosed Prevalent Cases in Japan
- Figure 22: Diabetic Foot Ulcer Gender-Specific Diagnosed Prevalent Cases in Japan
- Figure 23: Diabetic Foot Ulcer Age-Specific Diagnosed Prevalent Cases in Japan
- Figure 24: Diabetic Foot Ulcer Severity/chronicity of wound-specific Diagnosed Prevalent Cases in Japan
- Figure 25: Diabetic Foot Ulcer Total Treated Cases in Japan
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.